Medicare Enrolled
Dr. Alakananda Chakrabarty, MD
Internal Medicine · Coal Township, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chakrabarty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chakrabarty?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chakrabarty
Dr. Alakananda Chakrabarty is an internal medicine specialist in Coal Township, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chakrabarty performed 6,156 Medicare services across 1,808 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chakrabarty received a total of $15,358 from 61 pharmaceutical and/or device companies across 1168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chakrabarty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in PA
$15,358 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,156
Medicare services
Top 1% in PA for internal medicine
1,808
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~308 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,375 | $18 | $58 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
746 | $79 | $175 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
602 | $7 | $7 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
546 | $74 | $121 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
427 | $59 | $135 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
248 | $126 | $175 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
160 | $29 | $40 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
145 | $35 | $75 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
144 | $76 | $85 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
121 | $7 | $20 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
114 | $4 | $32 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
104 | $45 | $110 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
72 | $9 | $40 |
| Injection, methylprednisolone acetate, 40 mg | 57 | $4 | $20 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
56 | $15 | $60 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
52 | $3 | $6 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
50 | $206 | $325 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
45 | $53 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $130 | $220 |
| Nursing facility discharge management, 30 minutes or less This service covers the management of a patient's discharge from a nursing facility. It applies when the total time spent on discharge activities is 30 minutes or less. |
18 | $57 | $175 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
15 | $33 | $45 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $155 | $235 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
11 | $128 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,358
Total received (2018-2024)
Avg $2,194/year across 7 years
Top 5% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,290 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,826
2023
$1,715
2022
$2,013
2021
$1,631
2020
$1,539
2019
$3,301
2018
$3,333
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$564
Novo Nordisk Inc
$230
Axsome Therapeutics, Inc.
$186
Amgen Inc.
$183
PFIZER INC.
$152
Boehringer Ingelheim Pharmaceuticals, Inc.
$83
Esperion Therapeutics, Inc.
$81
Janssen Pharmaceuticals, Inc
$75
Lilly USA, LLC
$57
ABBVIE INC.
$54
Merck Sharp & Dohme LLC
$28
Exact Sciences Corporation
$28
Lundbeck LLC
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Kowa Pharmaceuticals America, Inc.
$18
GlaxoSmithKline, LLC.
$16
MDD US Operations, LLC
$16
CeQur Corporation
$9
Top 3 companies account for 53.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,889
Novo Nordisk Inc
$1,900
Amgen Inc.
$1,597
PFIZER INC.
$1,046
Boehringer Ingelheim Pharmaceuticals, Inc.
$980
Lilly USA, LLC
$755
SANOFI-AVENTIS U.S. LLC
$595
GlaxoSmithKline, LLC.
$455
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$450
Astellas Pharma US Inc
$424
Takeda Pharmaceuticals U.S.A., Inc.
$349
Supernus Pharmaceuticals, Inc.
$320
AbbVie Inc.
$285
ABBVIE INC.
$256
Janssen Pharmaceuticals, Inc
$247
Bayer HealthCare Pharmaceuticals Inc.
$242
Novartis Pharmaceuticals Corporation
$221
E.R. Squibb & Sons, L.L.C.
$213
Axsome Therapeutics, Inc.
$186
Radius Health, Inc.
$182
Amarin Pharma Inc.
$182
Merck Sharp & Dohme LLC
$136
Allergan, Inc.
$130
Kowa Pharmaceuticals America, Inc.
$111
Esperion Therapeutics, Inc.
$109
Merck Sharp & Dohme Corporation
$105
Exact Sciences Corporation
$79
Sumitomo Pharma America, Inc.
$76
Mylan Specialty L.P.
$71
Electromed, Inc.
$57
Lundbeck LLC
$52
Bayer Healthcare Pharmaceuticals Inc.
$50
Shield Therapeutics Inc
$45
Genentech USA, Inc.
$43
Amneal Pharmaceuticals LLC
$39
Otsuka America Pharmaceutical, Inc.
$38
Circassia Pharmaceuticals Inc
$33
Seqirus USA Inc
$26
Daiichi Sankyo Inc.
$26
Eisai Inc.
$25
Ironwood Pharmaceuticals, Inc
$23
Sunovion Pharmaceuticals Inc.
$23
ACADIA Pharmaceuticals Inc
$20
Zealand Pharma US, Inc.
$19
UROVANT SCIENCES INC
$19
SCILEX PHARMACEUTICALS INC.
$18
AbbVie, Inc.
$17
Abbott Laboratories
$17
Scilex Pharmaceuticals Inc.
$17
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$16
MDD US Operations, LLC
$16
OPKO Pharmaceuticals, LLC
$16
Regeneron Healthcare Solutions, Inc.
$15
Xeris Pharmaceuticals, Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
Purdue Pharma L.P.
$12
ITI, Inc.
$12
IRONWOOD PHARMACEUTICALS, INC
$11
Shionogi Inc
$11
Synergy Pharmaceuticals Inc
$11
CeQur Corporation
$9
Top 3 companies account for 41.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Auvelity · BASAGLAR · BELBUCA · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · Belviq · CAMZYOS · CAPLYTA · CHANTIX · COMBIVENT RESPIMAT · CREON · CeQur Simplicity · Cologuard Collection Kit · DIFICID · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FASENRA · FORTEO · FREESTYLE LIBRE 3 · Fluad · GARDASIL 9 · GEMTESA · GVOKE PFS · Gocovri · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Morphabond ER · Motegrity · Movantik · NEXLETOL · NUCALA · NUPLAZID · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PRADAXA · PRALUENT · PREVNAR - 13 · Prolia · QELBREE · QULIPTA · RELISTOR · RELISTOR ORAL · REXULTI · RYBELSUS · RYTARY · Rayaldee · Repatha · Rybelsus · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYMPROIC · SYNTHROID · Saxenda · Symproic · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TRUMENBA · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · Utibron · VARIVAX · VERQUVO · VIAGRA · VIBERZI · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · Xofluza · Xultophy 100/3.6 · Yupelri · ZEGALOGUE · ZORYVE · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for internal medicine in PA.
Geographic Context
Internal medicine physicians within 10 mi
250
Per 100K population
275.0
County median income
$57,948
Nearest hospital
GEISINGER MEDICAL CENTER
13.7 mi
13.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chakrabarty is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 5% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chakrabarty experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Chakrabarty performed 2,375 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chakrabarty receive payments from pharmaceutical companies?
Yes. Dr. Chakrabarty received a total of $15,358 from 61 companies across 1,168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chakrabarty's costs compare to other internal medicine physicians in Coal Township?
Dr. Chakrabarty's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chakrabarty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Coal Township
Browse internal medicine physicians in Coal Township ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology